ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 50 filers reported holding ALIGOS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $4,989,000 | 4.98% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $1,885,000 | 0.89% |
| Vivo Capital, LLC | 3,547,030 | $7,626,000 | 0.52% |
| EcoR1 Capital, LLC | 3,948,360 | $8,489,000 | 0.27% |
| Novo Holdings A/S | 1,950,000 | $4,193,000 | 0.22% |
| Boxer Capital, LLC | 1,526,048 | $3,281,000 | 0.17% |
| HHLR ADVISORS, LTD. | 2,365,064 | $5,085,000 | 0.11% |
| XTX Topco Ltd | 43,936 | $94,000 | 0.04% |
| Baker Brothers Advisors | 2,076,400 | $4,464,000 | 0.03% |
| IndexIQ Advisors LLC | 192,976 | $415,000 | 0.02% |